4319-88-4 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromo-4-chloro-6-methoxypyrimidine is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of antiviral and antifungal drugs. Its unique structure allows for the creation of various medicinal compounds that can target specific pathogens and diseases.
Used in Agrochemical Industry:
In the agrochemical industry, 5-Bromo-4-chloro-6-methoxypyrimidine is used as a key intermediate in the synthesis of herbicides and pesticides. Its incorporation into these products helps to enhance their effectiveness in controlling and eliminating unwanted plant species and pests, thereby supporting agricultural productivity.
Used in Organic Chemistry Research:
5-Bromo-4-chloro-6-methoxypyrimidine is also utilized in organic chemistry research for its versatility in chemical synthesis. Researchers use 5-BroMo-4-chloro-6-MethoxypyriMidine to explore new methods and reactions, potentially leading to the discovery of novel compounds and applications across various scientific fields.
Check Digit Verification of cas no
The CAS Registry Mumber 4319-88-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,1 and 9 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 4319-88:
(6*4)+(5*3)+(4*1)+(3*9)+(2*8)+(1*8)=94
94 % 10 = 4
So 4319-88-4 is a valid CAS Registry Number.
4319-88-4Relevant academic research and scientific papers
SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS
-
Paragraph 0652, (2020/07/14)
The present disclosure provides compounds having Formula I: and the pharmaceutically acceptable salts and solvates thereof, wherein X1, X2, X11, X12, R1, R3, R5, R5', R6, and R7 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to inhibit a USP1 protein and/or to treat a disorder responsive to the inhibition of USP1 proteins and USP1 activity. Compounds of the present disclosure are especially useful for treating cancer.
